GARAGE
Near-unicorn Prestige Biopharma eyes early-2021 IPO in South Korea
Singapore
SINGAPORE-BASED Prestige Biopharma is in the midst of pursuing an initial public offering (IPO) on the Korea Exchange, with a targeted listing in early 2021, the firm's chief executive Lisa Park said in response to queries from The Business Times (BT).
Earlier on Friday,
To find out more
Need help?
CALL +65 6388 3838 EMAIL btocs@sph.com.sg
More Stories
Trendlines surges to 10-month high after letter of intent for portfolio company
SHARES of The Trendlines Group jumped to a 10-month high on Tuesday after the company said it received a non-binding letter of intent (LOI) for...
Deliveroo's bleak IPO unlikely to have major impact on tech listings
DELIVEROO'S flop on the London bourse seems more like an instance of bad timing and market conditions in the UK, coupled with concerns about its...
Econ Healthcare files to relist on Catalist
FORMER Catalist-listed private nursing home operator Econ Healthcare is looking to list on the Catalist board of the Singapore Exchange again.